Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endovascular Procedures | 8 | 2024 | 270 | 1.470 |
Why?
|
Blood Vessel Prosthesis Implantation | 7 | 2024 | 226 | 1.310 |
Why?
|
Aortic Aneurysm, Abdominal | 5 | 2022 | 120 | 1.210 |
Why?
|
Peripheral Arterial Disease | 4 | 2024 | 94 | 1.050 |
Why?
|
Pseudomonas aeruginosa | 5 | 2012 | 202 | 0.960 |
Why?
|
Pseudomonas Infections | 4 | 2012 | 99 | 0.960 |
Why?
|
Aneurysm | 1 | 2013 | 60 | 0.430 |
Why?
|
Peritonitis | 1 | 2012 | 29 | 0.420 |
Why?
|
Opportunistic Infections | 1 | 2012 | 60 | 0.410 |
Why?
|
Adhesins, Bacterial | 1 | 2012 | 36 | 0.400 |
Why?
|
Sepsis | 3 | 2012 | 319 | 0.400 |
Why?
|
Lectins | 1 | 2012 | 84 | 0.400 |
Why?
|
Blood Vessel Prosthesis | 5 | 2022 | 242 | 0.390 |
Why?
|
Hepatectomy | 1 | 2012 | 170 | 0.380 |
Why?
|
Morphine | 1 | 2012 | 130 | 0.370 |
Why?
|
Intestines | 3 | 2012 | 416 | 0.370 |
Why?
|
Aortic Rupture | 2 | 2020 | 57 | 0.350 |
Why?
|
Postoperative Complications | 5 | 2024 | 2275 | 0.350 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2022 | 89 | 0.350 |
Why?
|
Popliteal Artery | 2 | 2023 | 28 | 0.340 |
Why?
|
Stents | 3 | 2022 | 395 | 0.290 |
Why?
|
Analgesics, Opioid | 1 | 2012 | 442 | 0.290 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 805 | 0.280 |
Why?
|
Emergencies | 2 | 2024 | 121 | 0.280 |
Why?
|
Prosthesis Design | 4 | 2022 | 296 | 0.260 |
Why?
|
Decision Support Techniques | 2 | 2024 | 167 | 0.260 |
Why?
|
Lower Extremity | 1 | 2024 | 87 | 0.220 |
Why?
|
Saphenous Vein | 1 | 2023 | 61 | 0.220 |
Why?
|
Random Allocation | 3 | 2012 | 328 | 0.220 |
Why?
|
Virulence | 3 | 2012 | 280 | 0.210 |
Why?
|
Risk Factors | 8 | 2024 | 5466 | 0.190 |
Why?
|
Self Expandable Metallic Stents | 1 | 2020 | 7 | 0.190 |
Why?
|
Treatment Outcome | 7 | 2024 | 8203 | 0.190 |
Why?
|
Situs Inversus | 1 | 2020 | 15 | 0.180 |
Why?
|
Aortography | 1 | 2020 | 65 | 0.180 |
Why?
|
Catheterization, Peripheral | 1 | 2020 | 60 | 0.180 |
Why?
|
Jehovah's Witnesses | 1 | 2020 | 20 | 0.180 |
Why?
|
Upper Extremity | 1 | 2020 | 52 | 0.180 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 80 | 0.180 |
Why?
|
Retrospective Studies | 9 | 2024 | 9003 | 0.170 |
Why?
|
Aorta, Thoracic | 1 | 2020 | 166 | 0.170 |
Why?
|
Computed Tomography Angiography | 1 | 2020 | 146 | 0.160 |
Why?
|
Risk Assessment | 5 | 2024 | 2291 | 0.160 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 469 | 0.140 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 149 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 859 | 0.140 |
Why?
|
Phosphates | 3 | 2012 | 160 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 595 | 0.140 |
Why?
|
Humans | 17 | 2024 | 89073 | 0.120 |
Why?
|
Aged | 8 | 2024 | 19078 | 0.120 |
Why?
|
Aged, 80 and over | 5 | 2024 | 6777 | 0.120 |
Why?
|
Mice | 6 | 2012 | 11742 | 0.110 |
Why?
|
Caenorhabditis elegans | 3 | 2012 | 230 | 0.110 |
Why?
|
Brachial Artery | 1 | 2013 | 36 | 0.110 |
Why?
|
Physicians | 1 | 2021 | 689 | 0.110 |
Why?
|
Femoral Artery | 1 | 2013 | 83 | 0.110 |
Why?
|
Time Factors | 4 | 2024 | 5320 | 0.110 |
Why?
|
Aneurysm, False | 1 | 2013 | 54 | 0.110 |
Why?
|
Axilla | 1 | 2013 | 104 | 0.110 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 123 | 0.110 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2012 | 78 | 0.100 |
Why?
|
Algorithms | 1 | 2020 | 1875 | 0.100 |
Why?
|
Candida albicans | 1 | 2012 | 32 | 0.100 |
Why?
|
Leiomyomatosis | 1 | 2012 | 12 | 0.100 |
Why?
|
Chemotaxis | 1 | 2012 | 73 | 0.100 |
Why?
|
Virulence Factors | 1 | 2012 | 112 | 0.100 |
Why?
|
Phenotype | 3 | 2012 | 2439 | 0.090 |
Why?
|
Mice, Inbred C57BL | 3 | 2012 | 3211 | 0.090 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2012 | 282 | 0.090 |
Why?
|
Reperfusion Injury | 1 | 2011 | 140 | 0.090 |
Why?
|
Metagenome | 1 | 2011 | 104 | 0.090 |
Why?
|
Vena Cava, Inferior | 1 | 2012 | 145 | 0.090 |
Why?
|
Male | 9 | 2024 | 42254 | 0.090 |
Why?
|
Gastrointestinal Tract | 1 | 2012 | 191 | 0.090 |
Why?
|
Intestine, Small | 1 | 2011 | 299 | 0.090 |
Why?
|
Endoleak | 2 | 2021 | 41 | 0.080 |
Why?
|
Female | 9 | 2024 | 46014 | 0.080 |
Why?
|
Critical Illness | 1 | 2012 | 306 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2011 | 229 | 0.080 |
Why?
|
Cytokines | 1 | 2012 | 802 | 0.080 |
Why?
|
Animals | 6 | 2012 | 27324 | 0.080 |
Why?
|
Middle Aged | 6 | 2024 | 25865 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2012 | 245 | 0.070 |
Why?
|
Biomarkers | 1 | 2012 | 1755 | 0.070 |
Why?
|
Registries | 2 | 2021 | 778 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2018 | 360 | 0.060 |
Why?
|
Vascular Grafting | 1 | 2024 | 16 | 0.060 |
Why?
|
Limb Salvage | 1 | 2024 | 35 | 0.060 |
Why?
|
Treatment Failure | 1 | 2024 | 287 | 0.060 |
Why?
|
Vulnerable Populations | 1 | 2024 | 83 | 0.060 |
Why?
|
Social Determinants of Health | 1 | 2024 | 95 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 582 | 0.050 |
Why?
|
Coronary Artery Bypass | 1 | 2023 | 234 | 0.050 |
Why?
|
United States | 2 | 2024 | 6957 | 0.050 |
Why?
|
Peru | 1 | 2021 | 23 | 0.050 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2020 | 42 | 0.050 |
Why?
|
Patient-Specific Modeling | 1 | 2020 | 20 | 0.050 |
Why?
|
Aneurysm, Ruptured | 1 | 2020 | 54 | 0.050 |
Why?
|
Vascular Patency | 1 | 2020 | 126 | 0.050 |
Why?
|
Logistic Models | 1 | 2024 | 1212 | 0.040 |
Why?
|
Finite Element Analysis | 1 | 2020 | 78 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2020 | 106 | 0.040 |
Why?
|
Aorta | 1 | 2020 | 288 | 0.040 |
Why?
|
Retreatment | 1 | 2018 | 108 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2018 | 99 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 2657 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 1715 | 0.030 |
Why?
|
Sex Factors | 1 | 2018 | 1063 | 0.030 |
Why?
|
Comorbidity | 1 | 2018 | 948 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2011 | 2362 | 0.030 |
Why?
|
Prognosis | 1 | 2020 | 3773 | 0.030 |
Why?
|
Acid Phosphatase | 1 | 2012 | 34 | 0.030 |
Why?
|
Bacterial Translocation | 1 | 2011 | 26 | 0.030 |
Why?
|
Bacterial Adhesion | 1 | 2011 | 84 | 0.020 |
Why?
|
Biofilms | 1 | 2012 | 46 | 0.020 |
Why?
|
Stroke | 1 | 2020 | 982 | 0.020 |
Why?
|
Microbiological Techniques | 1 | 2011 | 24 | 0.020 |
Why?
|
Fungal Proteins | 1 | 2012 | 141 | 0.020 |
Why?
|
Genetic Techniques | 1 | 2011 | 73 | 0.020 |
Why?
|
Reference Values | 1 | 2011 | 661 | 0.020 |
Why?
|
Drug Design | 1 | 2011 | 125 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 2011 | 79 | 0.020 |
Why?
|
Symbiosis | 1 | 2011 | 126 | 0.020 |
Why?
|
Feces | 1 | 2012 | 327 | 0.020 |
Why?
|
Color | 1 | 2009 | 85 | 0.020 |
Why?
|
General Surgery | 1 | 2011 | 235 | 0.020 |
Why?
|
Iron | 1 | 2009 | 168 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 866 | 0.020 |
Why?
|
Genome, Bacterial | 1 | 2009 | 148 | 0.020 |
Why?
|
Survival Analysis | 1 | 2011 | 1533 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 3027 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2012 | 1157 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 3657 | 0.020 |
Why?
|
Adult | 1 | 2020 | 26508 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 4132 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 3443 | 0.010 |
Why?
|